Method of providing a pattern of biological-binding areas for biological testing
The present invention provides a method of forming one or more biological-binding areas on a substrate for biological-testing. The method includes activating at least a portion of a glass-ceramic substrate comprising glass and one or more metal containing compounds. The one or more metal containing compounds have a range of diameters that are less than about 300 nanometers in diameter and are spaced an average distance of at least one-half the midpoint of the diameter range apart. The one or more metals include compounds selected from metal oxides, metal nanoparticles, metal alloys, and atomic metals. The glass-ceramic substrate is heated to a temperature near the glass transformation temperature to form one or more metal nanoparticles in one or more ceramic biological-binding areas. The glass-ceramic substrate is etched to expose one or more metal. One or more biological molecules are contacted with one or more ceramic biological-binding areas to provide one or more biological testing areas with an increased binding area as compared to un-activated areas.
1. A method of forming one or more metallic areas on a substrate for biological-testing, comprising the steps of:
providing a photosensitive glass-ceramic substrate comprising a photosensitive glass-ceramic substrate and one or more metal containing compounds selected from metal oxides, metal nanoparticles, metal alloys, and atomic metals with a range of diameters that are less than about 300 nanometers and are spaced an average distance of at least one-half the midpoint of the diameter range apart;
activating at least a portion of the photosensitive glass-ceramic substrate to form a pattern;
heating the photosensitive glass-ceramic substrate to a temperature near a glass transformation temperature of the photosensitive glass-ceramic substrate to form one or more congregated metal nanoparticles in the photosensitive glass-ceramic substrate;
baking the photosensitive glass-ceramic substrate to convert the one or more congregated metal nanoparticles into one or more metallic biological-binding areas; and
etching the photosensitive glass-ceramic substrate to expose the one or more metallic biological-binding areas with an enhanced adherence to biological molecules.
2. The method of claim 1 , further comprising the step of applying a pattern mask by screen printing, photolithography or a combination thereof on at least a portion of the photosensitive glass-ceramic substrate to protect from activation.
3. The method of claim 1 , further comprising the step of applying an etching pattern mask by screen printing, photolithography or a combination thereof on at least a portion of the photosensitive glass-ceramic substrate to protect from etching.
4. The method of claim 1 , wherein the step of activating comprises exposing to an UV activating energy source.
5. The method of claim 1 , wherein the one or more metal containing compounds comprise silver, gold, platinum, rhodium, palladium, nickel, cobalt, copper, or alloys or combinations thereof.
6. The method of claim 1 , wherein the one or more metal oxides are exposed to high-energy particles to reduce the one or more metal oxides to one or more metal nanoparticles.
7. The method of claim 1 , wherein the one or more congregated metal nanoparticles are formed by metal-precipitating one or more metal nanoparticles from metal oxides.
8. The method of claim 1 , wherein the one or more congregated metal nanoparticles are assayed by techniques using surface plasmon excitation.
9. The method of claim 8 , wherein one or more congregated metal nanoparticles undergo analysis by surface enhanced fluorescence (SEF), metal enhanced fluorescence (MEF), surface enhanced Raman scattering (SERS), surface plasmon resonance (SPR) or surface enhanced resonance Raman scattering (SERRS).
10. The method of claim 1 , further comprising the step of contacting one or more biological molecules to the one or more ceramic biological-binding areas, wherein the one or more biological molecules comprise one or more chromophores, one or more fluorophore, one or more luminescent compounds, one or more radioactive labels or a combination thereof
11. The method of claim 1 , further comprising the step of attaching one or more biological molecules to the one or more metallic biological-binding areas and contacting the one or more biological molecules with a target molecule wherein the target molecule, the one or more biological molecules or both independently comprise one or more DNA, RNA, PNA, proteins, peptides, carbohydrates, lipids, ligands, enzymes, phage antibody-display, ribosome display, kinases, drugs, receptors, hapten, pathogen, toxin, hormone, chemicals, liposomes, carbohydrate, organic compounds, compounds containing at least one non-binding electron pair, other biological compounds or combinations thereof.
12. The method of claim 1 , wherein the one or more metal containing compounds are added as one or more metal particles during fabrication of the photosensitive glass-ceramic substrate.
13. The method of claim 1 , wherein the one or more metal containing compounds are added as a metal salt during fabrication of the photosensitive glass-ceramic substrate.
14. The method of claim 1 , further comprising the step of contacting one or more biological molecules to the one or more metallic biological-binding areas wherein the one or more biological molecules.
15. The method of claim 14 , further comprising the step of contacting one or more second biological molecules to the one or more second biological molecules to form a capture detect assay, wherein the one or more second biological molecules comprise one or more DNA, RNA, PNA, proteins, peptides, carbohydrates, lipids, ligands, enzymes, phage antibody-display, ribosome display, kinases, drugs, receptors, hapten, pathogen, toxin, hormone, chemicals, liposomes, carbohydrate, organic compounds, compounds containing at least one non-binding electron pair, other biological compounds or combinations thereof.